ReviewBMC pediatrics2026
Identification of a novel nonsense mutation (c.1369 C > T) in the WAS gene in a neonate: a case report and literature review.
Review in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundWiskott-Aldrich syndrome (WAS) is an X-linked recessive primary immunodeficiency disorder characterized by the classic triad of microthrombocytopenia, eczema, and recurrent infections. However, neonatal onset often presents atypically, making early diagnosis challenging. CASE REPORT: We report a male neonate presenting with spontaneous petechiae, intractable thrombocytopenia, anemia, and leukopenia on the first day of life. The patient was initially misdiagnosed with immune thrombocytopenia (ITP) and showed refractoriness to conventional first-line (IVIG, corticosteroids) and second-line (recombinant human thrombopoietin) therapies. Trio-whole exome sequencing (Trio-WES) identified a novel hemizygous nonsense mutation, c.1369 C > T (p.Q457X), in exon 11 of the WAS gene. Bioinformatic analysis suggests this mutation leads to the loss of the critical C-terminal VCA domain of the WASP protein.
conclusionThis case expands the mutational spectrum of WAS. It highlights that for male neonates with unexplained thrombocytopenia—particularly those with reduced mean platelet volume (MPV)—early genetic testing is crucial to avoid misdiagnosis and inappropriate immunosuppressive treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.